Dr. Andrew S. Kennedy
Claim this profileHenrico Doctor's Hospital
Studies Breast Cancer
Studies Stomach Cancer
7 reported clinical trials
28 drugs studied
Area of expertise
1Breast Cancer
ER positive
HER2 negative
Stage II
2Stomach Cancer
HER2 positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Andrew S. Kennedy is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Surgery and Radiation vs. Radiation Alone
for Brain Cancer
This phase III trial compares the usual treatment of surgery after stereotactic radiosurgery (SRS) to receiving SRS before surgery in treating patients with cancer that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of radiation therapy that delivers a high dose of radiation to target tumors and minimizes effect on normal surrounding brain tissue. The combination of surgery and radiation may stop the tumor from growing for a few months or longer and may reduce symptoms of brain metastases. This study investigates whether treating with SRS before surgery may be better than SRS after surgery in reducing the possibility of the tumor coming back, reducing or preventing the cancer from spreading to other areas of the brain and reducing the risk of scarring on the brain from radiation.
Recruiting2 awards Phase 3
More about Andrew S. Kennedy
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Andrew S. Kennedy has experience with
- Radiation
- Anastrozol
- Exemestane
- Letrozole
- Tamoxifen
- Bicalutamide
Breakdown of trials Andrew S. Kennedy has run
Breast Cancer
Stomach Cancer
Relapse
Prostate Adenocarcinoma
Brain Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Andrew S. Kennedy specialize in?
Is Andrew S. Kennedy currently recruiting for clinical trials?
Are there any treatments that Andrew S. Kennedy has studied deeply?
What is the best way to schedule an appointment with Andrew S. Kennedy?
What is the office address of Andrew S. Kennedy?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.